Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
inositol hexakisphosphate kinase 3 | 0.839 | 0.231 | 3.1E-07 |
|
disease | 0.100 | None | 1.000 | 3 | 8 | 2007 | 2011 | ||||||||
|
PPT2-EGFL8 readthrough (NMD candidate) | 0.792 | 0.462 |
|
disease | 0.100 | None | 1.000 | 3 | 6 | 2007 | 2011 | |||||||||
|
complement C2 | 0.617 | 0.692 | 1.3E-16 |
|
disease | 0.120 | None | 1.000 | 3 | 13 | 1976 | 2011 | ||||||||
|
cytochrome P450 family 21 subfamily A member 2 | 0.525 | 0.769 | 2.6E-04 |
|
disease | 0.100 | None | 1.000 | 3 | 46 | 2007 | 2011 | ||||||||
|
solute carrier family 44 member 4 | 0.678 | 0.615 | 1.0E-14 |
|
disease | 0.100 | None | 1.000 | 3 | 9 | 2007 | 2011 | ||||||||
|
major histocompatibility complex, class I, S (pseudogene) | 0.931 | 0.192 |
|
disease | 0.100 | None | 1.000 | 3 | 1 | 2007 | 2011 | |||||||||
|
major histocompatibility complex, class II, DO alpha | 0.509 | 0.808 | 3.0E-10 |
|
disease | 0.140 | None | 1.000 | 3 | 10 | 1986 | 2016 | ||||||||
|
major histocompatibility complex, class II, DO beta | 0.705 | 0.500 | 1.9E-06 |
|
disease | 0.100 | None | 1.000 | 3 | 8 | 2007 | 2016 | ||||||||
|
proline rich coiled-coil 2A | 0.656 | 0.654 | 1.00 |
|
disease | 0.130 | None | 1.000 | 3 | 15 | 1998 | 2011 | ||||||||
|
HLA complex group 27 | 0.805 | 0.346 | 2.3E-02 |
|
disease | 0.100 | None | 1.000 | 3 | 4 | 2007 | 2011 | ||||||||
|
BAG cochaperone 6 | 0.674 | 0.615 | 1.00 |
|
disease | 0.100 | None | 1.000 | 3 | 12 | 2007 | 2011 | ||||||||
|
G-patch domain and ankyrin repeats 1 | 0.769 | 0.385 | 3.2E-07 |
|
disease | 0.100 | None | 1.000 | 3 | 3 | 2007 | 2011 | ||||||||
|
DExD-box helicase 39B | 0.641 | 0.808 | 1.00 |
|
disease | 0.130 | None | 1.000 | 3 | 8 | 2001 | 2011 | ||||||||
|
membrane metalloendopeptidase like 1 | 0.606 | 0.692 | 1.2E-22 |
|
disease | 0.440 | None | 0.909 | 3 | 2 | 2008 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 2 | 0.617 | 0.769 | 1.0E-05 |
|
disease | 0.400 | None | 1.000 | 3 | 15 | 2007 | 2011 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.200 | None | 1.000 | 3 | 4 | 1997 | 2017 | ||||||||
|
leukocyte specific transcript 1 | 0.792 | 0.308 | 1.1E-03 |
|
disease | 0.130 | None | 1.000 | 3 | 2 | 2006 | 2016 | ||||||||
|
major histocompatibility complex, class II, DP alpha 1 | 0.552 | 0.846 | 2.5E-06 |
|
disease | 0.140 | None | 0.857 | 3 | 8 | 1990 | 2017 | ||||||||
|
major histocompatibility complex, class II, DQ beta 2 | 0.573 | 0.731 | 4.3E-02 |
|
disease | 0.100 | None | 1.000 | 3 | 3 | 2007 | 2011 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.200 | None | 1.000 | 3 | 43 | 1982 | 2018 | ||||||||
|
tenascin XB | 0.572 | 0.731 | 1.9E-02 |
|
disease | 0.110 | None | 1.000 | 3 | 23 | 2001 | 2011 | ||||||||
|
family with sequence similarity 107 member A | 0.674 | 0.462 | 8.3E-07 |
|
disease | 0.100 | None | 1.000 | 3 | 1 | 2010 | 2012 | ||||||||
|
serine/threonine kinase 19 | 0.691 | 0.500 | 6.7E-09 |
|
disease | 0.100 | None | 1.000 | 3 | 5 | 2007 | 2011 | ||||||||
|
notch receptor 4 | 0.534 | 0.731 | 2.1E-23 |
|
disease | 0.150 | None | 1.000 | 3 | 23 | 2001 | 2013 | ||||||||
|
Ski2 like RNA helicase | 0.615 | 0.654 | 1.3E-22 |
|
disease | 0.100 | None | 1.000 | 3 | 6 | 2007 | 2011 |